GENEVA, July 6 -- SIRONAX SWITZERLAND GMBH filed a patent application (CN2024/143064) for “BISPECIFIC ANTIBODIES TARGETING AMYLOID BETA AND HUMAN CD98HC AND METHODS OF USES”. With publication no. WO/2026/137379, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/46
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....